Literature DB >> 28459348

Symptom Characteristics and Medical History of an Online Sample of Women Who Experience Symptoms of Persistent Genital Arousal.

Robyn Jackowich1, Leah Pink2, Allan Gordon2, Évéline Poirier1, Caroline F Pukall1.   

Abstract

Persistent genital arousal disorder (PGAD; Leiblum & Nathan, 2001 ) is characterized by distressing symptoms suggestive of genital arousal in the absence of subjective feelings of arousal. Although awareness of PGAD is growing, there continues to be a lack of systematic research on it. This study characterized an online sample of women with symptoms of persistent genital arousal (PGA) in terms of their symptom characteristics, medical comorbidities, symptom triggers, management strategies, and predictors of distress. Women reported diverse PGA symptoms, with almost half reporting painful symptoms, and most reported very high distress and negative emotions. Further research and awareness of PGA are needed to provide effective care for this population.

Entities:  

Mesh:

Year:  2017        PMID: 28459348     DOI: 10.1080/0092623X.2017.1321598

Source DB:  PubMed          Journal:  J Sex Marital Ther        ISSN: 0092-623X


  4 in total

1.  Persistent genital arousal disorder: a special sense neuropathy.

Authors:  Anne Louise Oaklander; Saurabh Sharma; Katie Kessler; Bruce H Price
Journal:  Pain Rep       Date:  2020-01-07

2.  Enduring sexual dysfunction after treatment with antidepressants, 5α-reductase inhibitors and isotretinoin: 300 cases.

Authors:  David Healy; Joanna Le Noury; Derelie Mangin
Journal:  Int J Risk Saf Med       Date:  2018

3.  Citizen petition: Sexual side effects of SSRIs and SNRIs.

Authors:  David Healy
Journal:  Int J Risk Saf Med       Date:  2018

4.  Online Pelvic Floor Group Education Program for Women With Persistent Genital Arousal Disorder/Genito-Pelvic Dysesthesia: Descriptive Feasibility Study.

Authors:  Robyn A Jackowich; Kayla M Mooney; Evelyn Hecht; Caroline F Pukall
Journal:  JMIR Form Res       Date:  2021-01-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.